INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2002

Genistein supplementation improved bone mineral density and bone turnover markers in postmenopausal women.

A randomized controlled trial assigned 90 healthy postmenopausal women to receive hormone replacement therapy, 54 mg/day of genistein, or placebo for one year. At 12 months, genistein increased femoral neck bone mineral density by 3.6 +/- 3% and lumbar spine density by 3 +/- 2% (P < 0.001 compared to placebo). Genistein also decreased urinary pyridinium cross-links and increased bone-specific alkaline phosphatase and osteocalcin.

Study type
Randomized controlled trial
Who was studied
90 postmenopausal women aged 47-57
What was measured
Bone mineral density and markers of bone turnover

THE PAPER

Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.

Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. J Bone Miner Res, 2002.

PubMed 12369794 ↗DOI 10.1359/jbmr.2002.17.10.1904 ↗

Nutrients & adequacyBones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.